Patients in our study, regardless of the diagnosis, exhibited weight loss and changes in eating behaviors after treatment, but a significant effect of NUCB2 polymorphism was only evident in the Ob-BED group. Here, NUCB2 is linked to X-linked cone dysfunction syndrome with myopia.